Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary

About this update from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining Notice of Approval for Drug Clinical Trials by SubsidiaryThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hunan Fangsheng Pharmaceutical Co., Ltd. Class A